Forman Mark S — SEC Form 4 filings
SEC reporting owner CIK 1922353. 7 Form 4 filings on record with FilingPulse; latest filed 2026-03-04.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-13 to 2026-03-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 1,638 shares, $1,589 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: sale of 1,638 shares @ $0.97 ($1,589) in Passage BIO, Inc., filed 2024-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Passage BIO, Inc. (PASG) | CHIEF MEDICAL OFFICER | 2 | — | 1 leg · 1,638 sh · $1,589 | 6 |
| Ventyx Biosciences, Inc. (VTYX) | Chief Medical Officer | 5 | — | — | 7 |
Form 4 filings — Forman Mark S
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-03-04 | 4 | Ventyx Biosciences, Inc. (VTYX) | Disposition to issuer (D): 6,000 · Disposition to issuer (D): 85,000 (derivative) · Disposition to issuer (D): 350,000 (derivative) | EDGAR |
| 2025-11-19 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 3,000 @ $1.03 | EDGAR |
| 2025-05-16 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 3,000 @ $1.03 | EDGAR |
| 2025-01-03 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 85,000 (derivative) @ $0 | EDGAR |
| 2024-08-13 | 4 | Ventyx Biosciences, Inc. (VTYX) | Grant/award (A): 350,000 (derivative) @ $0 | EDGAR |
| 2024-03-19 | 4 | Passage BIO, Inc. (PASG) | Grant/award (A): 203,000 (derivative) @ $0 | EDGAR |
| 2024-02-13 | 4 | Passage BIO, Inc. (PASG) | Option exercise (M): 5,000 · Sale (S): 1,638 @ $0.97 · Grant/award (A): 130,000 (derivative) @ $0 · Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 15,000 (derivative) @ $0 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1922353 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →